Cargando…

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates

A recombinant vesicular stomatitis virus (rVSV) expressing the Marburg virus (MARV) Musoke variant glycoprotein fully protects macaques against 2 MARV variants and Ravn virus as a preventive vaccine and MARV variant Musoke as a postexposure treatment. To evaluate postexposure efficacy against the mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woolsey, Courtney, Geisbert, Joan B, Matassov, Demetrius, Agans, Krystle N, Borisevich, Viktoriya, Cross, Robert W, Deer, Daniel J, Fenton, Karla A, Eldridge, John H, Mire, Chad E, Geisbert, Thomas W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249565/ https://www.ncbi.nlm.nih.gov/pubmed/29939296 http://dx.doi.org/10.1093/infdis/jiy293

Ejemplares similares

Immune correlates of postexposure vaccine protection against Marburg virus
por: Woolsey, Courtney, et al.
Publicado: (2020)

Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2014)

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
por: Woolsey, Courtney, et al.
Publicado: (2022)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease
por: Mire, Chad E., et al.
Publicado: (2019)

Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease
por: Woolsey, Courtney, et al.
Publicado: (2023)

Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo)
por: Cross, Robert W, et al.
Publicado: (2018)

Postexposure Treatment of Marburg Virus Infection
por: Geisbert, Thomas W., et al.
Publicado: (2010)

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
por: Mire, Chad E., et al.
Publicado: (2016)

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
por: Foster, Stephanie L., et al.
Publicado: (2022)

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
por: Cross, Robert W., et al.
Publicado: (2021)

Natural history of nonhuman primates after conjunctival exposure to Ebola virus
por: Cross, Robert W., et al.
Publicado: (2023)

Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials
por: Cooper, Christopher L., et al.
Publicado: (2022)

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
por: Matassov, Demetrius, et al.
Publicado: (2015)

Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2012)

Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease
por: Mire, Chad E, et al.
Publicado: (2013)

Combination therapy protects macaques against advanced Marburg virus disease
por: Cross, Robert W., et al.
Publicado: (2021)

Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
por: Cross, Robert W., et al.
Publicado: (2020)

An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys
por: Geisbert, Joan B, et al.
Publicado: (2020)

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus
por: Cross, Robert W., et al.
Publicado: (2023)

Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2016)

Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease
por: Cross, Robert W., et al.
Publicado: (2022)

Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys
por: Cross, Robert W., et al.
Publicado: (2020)

Single dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
por: Mire, Chad E., et al.
Publicado: (2015)

Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
por: Geisbert, Thomas W., et al.
Publicado: (2008)

Lipid nanoparticle siRNA treatment of Ebola virus Makona infected nonhuman primates
por: Thi, Emily P., et al.
Publicado: (2015)

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
por: Cross, Robert W, et al.
Publicado: (2020)

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
por: Cross, Robert W., et al.
Publicado: (2020)

Bundibugyo ebolavirus Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling
por: Woolsey, Courtney, et al.
Publicado: (2021)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015)

Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques
por: Woolsey, Courtney, et al.
Publicado: (2022)

Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy
por: Mire, Chad E., et al.
Publicado: (2016)

Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
por: Rodriguez, Sergio E., et al.
Publicado: (2019)

Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis
por: Menicucci, Andrea R., et al.
Publicado: (2017)

Protection Against Lethal Marburg Virus Infection Mediated by Lipid Encapsulated Small Interfering RNA
por: Ursic-Bedoya, Raul, et al.
Publicado: (2014)

Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
por: Versteeg, Krista, et al.
Publicado: (2017)

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
por: Safronetz, David, et al.
Publicado: (2015)

Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
por: Versteeg, Krista, et al.
Publicado: (2019)

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
por: Lehrer, Axel T., et al.
Publicado: (2021)

A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection
por: Mire, Chad E, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9jr5gtegade9rp4qms92ti7pqa